Трансформирующий фактор роста бета (Russian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Трансформирующий фактор роста бета" in Russian language version.

refsWebsite

Global rank Russian rank

4^th place

6^th place

2^nd place

3^rd place

doi.org

Tu, W. Z., Fu, Y. B., & Xie, X. (2019). RepSox, a small molecule inhibitor of the TGFβ receptor, induces brown adipogenesis and browning of white adipocytes. Acta Pharmacologica Sinica, 40(12), 1523-1531. PMID 31235818 PMC 7471457 doi:10.1038/s41401-019-0264-2
Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65–74. PMID 12065756 doi:10.1124/mol.62.1.65
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., ... & Imamura, T. (2005). The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β. Cancer science, 96(11), 791-800. PMID 16271073 doi:10.1111/j.1349-7006.2005.00103.x
Yingling, J. M., McMillen, W. T., Yan, L., Huang, H., Sawyer, J. S., Graff, J., ... & Driscoll, K. E. (2018). Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor. Oncotarget, 9(6), 6659. PMID 29467918 PMC 5805504 doi:10.18632/oncotarget.23795

Tu, W. Z., Fu, Y. B., & Xie, X. (2019). RepSox, a small molecule inhibitor of the TGFβ receptor, induces brown adipogenesis and browning of white adipocytes. Acta Pharmacologica Sinica, 40(12), 1523-1531. PMID 31235818 PMC 7471457 doi:10.1038/s41401-019-0264-2
Inman GJ, Nicolas FJ, Callahan JF, Harling JD, Gaster LM, Reith AD, Laping NJ, Hill CS. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. Mol Pharmacol. 2002;62:65–74. PMID 12065756 doi:10.1124/mol.62.1.65
Tojo, M., Hamashima, Y., Hanyu, A., Kajimoto, T., Saitoh, M., Miyazono, K., ... & Imamura, T. (2005). The ALK‐5 inhibitor A‐83‐01 inhibits Smad signaling and epithelial‐to‐mesenchymal transition by transforming growth factor‐β. Cancer science, 96(11), 791-800. PMID 16271073 doi:10.1111/j.1349-7006.2005.00103.x
Yingling, J. M., McMillen, W. T., Yan, L., Huang, H., Sawyer, J. S., Graff, J., ... & Driscoll, K. E. (2018). Preclinical assessment of galunisertib (LY2157299 monohydrate), a first-in-class transforming growth factor-β receptor type I inhibitor. Oncotarget, 9(6), 6659. PMID 29467918 PMC 5805504 doi:10.18632/oncotarget.23795